Why Is North America the Leading Market for Dalfampridine?
North America holds a dominant position in the global dalfampridine market, driven by high multiple sclerosis (MS) prevalence, advanced healthcare infrastructure, and the presence of the drug's manufacturer. The region's leadership is a critical factor shaping the direction of the Dalfampridine Market worldwide. High MS Prevalence and Advanced Healthcare Infrastructure The United States is the...
0 Комментарии 0 Поделились 272 Просмотры 0 предпросмотр